Family Medicine Board Review · Case-Based · Difficult Level

Thrombocytopenia — Clinical Vignette MCQs

Board-style cases built from the thrombocytopenia summary — pseudo-thrombocytopenia, bleeding risk thresholds, ITP/HIT/TTP recognition, procedure and transfusion math, and activity guidance. Tap "Reveal Answer" on each, then read the pearl.

15 Questions ●●●● Difficult Single Best Answer
Q1Pseudo-Thrombocytopenia●●●● Very Hard

A 40-year-old asymptomatic woman has a platelet count of 62 × 10³/µL on a routine CBC drawn in a standard EDTA tube. She has no bleeding symptoms, no bruising, and a normal physical exam. What is the most appropriate next step?

Reveal Answer

Correct answer: B

An unexpectedly low platelet count in an asymptomatic patient with no bleeding findings should first prompt consideration of pseudo-thrombocytopenia — caused by platelet clumping in the standard EDTA collection tube. The appropriate step is to repeat the count in a tube containing heparin or sodium citrate before pursuing any further workup or treatment.

Why the others are wrong A — transfusion is not indicated without confirming a true, clinically significant thrombocytopenia, and this patient is asymptomatic. C — starting steroids before confirming the count and excluding pseudo-thrombocytopenia is premature. D — bone marrow biopsy is invasive and not the appropriate first step before basic confirmation. E — antiplatelet antibody testing is part of a broader workup pursued later, not the immediate next step for an unconfirmed low count.
Exam Pearl Any unexpected low platelet count should be confirmed with a repeat count in a citrate or heparin tube before initiating workup or treatment — pseudo-thrombocytopenia from EDTA-induced clumping is common and easily overlooked.
Q2Age-Based Screening●●●●● Extreme

A 67-year-old man is found to have an isolated platelet count of 88 × 10³/µL on routine labs, with normal hemoglobin, normal WBC, and no other abnormalities. Pseudo-thrombocytopenia has been excluded with a repeat citrate-tube count. What is the most appropriate next consideration?

Reveal Answer

Correct answer: B

Any patient older than 60 years presenting with isolated thrombocytopenia should specifically be evaluated for myelodysplastic syndrome and lymphoproliferative disorders — age is a specific trigger for this expanded workup, regardless of how mild the count reduction is.

Why the others are wrong A — the isolated nature of the finding doesn't exempt him from this age-specific workup; in fact, it's the isolated pattern (in an older patient) that specifically triggers concern. C — splenectomy is a treatment reserved for confirmed, refractory ITP after prolonged appropriate management, not an immediate step for an undiagnosed finding. D — this is factually incorrect and the opposite of the correct teaching point. E — hydroxyurea isn't indicated without an established diagnosis requiring it.
Exam Pearl Age >60 + isolated thrombocytopenia = evaluate for MDS and lymphoproliferative disorders. This age-based trigger is a frequently tested standalone fact.
Q3Bleeding Risk Correlation●●●○ Hard

A 35-year-old woman with a platelet count of 8 × 10³/µL is being evaluated in clinic. She reports no obvious trauma. What type of bleeding is she at highest risk for at this platelet level?

Reveal Answer

Correct answer: C

A platelet count <10 × 10³/µL is associated with risk of spontaneous bleeding — the most severe bleeding risk category, occurring without any inciting trauma.

Why the others are wrong A — at this severely low count, bleeding risk is significant, not absent. B — this describes a milder risk category (closer to platelets >50, generally asymptomatic except with significant trauma/surgery), not the <10 range. D — bleeding risk at this level is independent of anticoagulant use; it occurs spontaneously due to the severely low platelet count alone. E — bruising/petechiae with minor trauma describes the 20–50 range; at <10, spontaneous and potentially more severe bleeding (including life-threatening hemorrhage) becomes a concern.
Exam Pearl Bleeding risk by count: >50 = usually asymptomatic; 20–50 = bruising/petechiae with minimal trauma; <10 = spontaneous bleeding. A platelet count <10 is also a specific indication for both hospitalization and platelet transfusion.
Q4Schistocytes / TTP Recognition●●●●● Extreme

A 42-year-old woman presents with fever, confusion, and petechiae. Labs show platelet count 18 × 10³/µL, hemoglobin 7.8 g/dL, and elevated LDH. Peripheral smear shows numerous schistocytes. What is the most appropriate immediate concern and next step?

Reveal Answer

Correct answer: B

Schistocytes on peripheral smear, combined with thrombocytopenia, anemia (with evidence of hemolysis via elevated LDH), fever, and neurologic changes (confusion), are concerning for microangiopathic hemolytic anemia — TTP or HUS, both hematologic emergencies requiring urgent recognition and management (e.g., plasma exchange for TTP).

Why the others are wrong A — ITP does not present with schistocytes or hemolysis; this presentation should specifically steer away from an ITP-only diagnosis, and steroids alone are inadequate/inappropriate management for suspected TTP. C — schistocytes are a specific, important, abnormal finding indicating microangiopathic hemolysis, not a normal variant. D — iron studies don't address the urgent concern raised by this presentation. E — this presentation (evidence of hemolysis, neurologic dysfunction, severe thrombocytopenia) meets several hospitalization criteria and requires urgent, not delayed outpatient, management.
Exam Pearl Schistocytes on smear = think TTP/HUS — this is a can't-miss diagnosis. Evidence of hemolysis and new neurologic dysfunction are both independently listed hospitalization criteria in thrombocytopenia, and this case meets both.
Q5DIC Recognition●●●●● Extreme

A 55-year-old man with septic shock develops a rapidly falling platelet count, oozing from IV sites, and elevated D-dimer with low fibrinogen. Which laboratory panel is most appropriate to further characterize this presentation?

Reveal Answer

Correct answer: B

In the setting of sepsis with thrombocytopenia, bleeding from multiple sites, elevated D-dimer, and low fibrinogen, the clinical concern is disseminated intravascular coagulation (DIC). The appropriate targeted evaluation is a DIC panel: fibrinogen, D-dimer, and coagulation factors.

Why the others are wrong A — a hemolytic panel addresses a different differential (hemolytic anemia processes) and isn't the primary panel to characterize this consumptive coagulopathy picture. C — B12/folate evaluates for nutritional causes of cytopenias, not this acute consumptive process. D — TSH addresses thyroid-related causes, unrelated to this acute presentation. E — stool antigen testing (e.g., for H. pylori) is unrelated to this acute coagulopathy picture.
Exam Pearl Match the lab panel to the clinical picture: sepsis + falling platelets + bleeding + abnormal coagulation studies → DIC panel (fibrinogen, D-dimer, coagulation factors) is the most directed next test.
Q6Drug-Induced Timing●●●● Very Hard

A 60-year-old man started a new antibiotic 6 days ago and now presents with a platelet count of 35 × 10³/µL, down from a normal baseline. The medication was discontinued 2 days ago. What is the most likely course going forward, and what timeline should be expected?

Reveal Answer

Correct answer: B

His timeline — thrombocytopenia developing 6 days after starting a new medication — fits squarely within the classic 3–10 day onset window for drug-induced thrombocytopenia. With the offending drug now stopped, the platelet count should be expected to improve within about 10 days of discontinuation.

Why the others are wrong A — drug-induced thrombocytopenia is typically self-limited after discontinuation; transfusion isn't required for eventual recovery in most cases. C — recovery is expected much sooner (within about 10 days), not 6 months. D — his timeline actually fits the classic pattern well, supporting rather than excluding this diagnosis. E — restarting the suspected offending medication would be inappropriate and could worsen or re-trigger the thrombocytopenia.
Exam Pearl Drug-induced thrombocytopenia: onset 3–10 days after exposure; recovery expected within 10 days of stopping the drug. Both windows are frequently tested together as a pair.
Q7ITP — Diagnosis of Exclusion●●●●● Extreme

A 26-year-old woman presents with new-onset petechiae and easy bruising. CBC shows platelet count 22 × 10³/µL with normal hemoglobin and normal WBC differential. Peripheral smear shows no schistocytes and normal-appearing red and white cells. What is the most important characteristic supporting a diagnosis of immune thrombocytopenia (ITP) in this case, and how is the diagnosis established?

Reveal Answer

Correct answer: B

ITP is defined by premature splenic destruction of antibody-coated platelets, with other hematopoietic cell lines remaining normal — matching this patient's isolated thrombocytopenia with normal Hgb and WBC. Critically, ITP is a diagnosis of exclusion — there is no single definitive confirmatory test; other causes must be ruled out first.

Why the others are wrong A — there is no single specific confirmatory test that definitively diagnoses ITP; it remains a diagnosis of exclusion. C — concurrent anemia or leukopenia would argue against isolated ITP and should prompt consideration of an alternative or additional process. D — bone marrow biopsy is not required in all ITP cases; it's used selectively (e.g., atypical presentations, older patients, poor treatment response), not as a universal diagnostic requirement. E — schistocytes are not a feature of ITP; their presence would point toward TTP/HUS instead.
Exam Pearl ITP = isolated thrombocytopenia (<100 × 10³/µL) with normal other cell lines, and it is a diagnosis of exclusion — no confirmatory test exists. Any additional cytopenia or abnormal smear finding (schistocytes) should prompt reconsideration of the diagnosis.
Q8ITP Treatment Ladder●●●● Very Hard

A 31-year-old woman with confirmed ITP (platelet count 9 × 10³/µL) is admitted for treatment. First-line therapy with steroids and IVIG is initiated. Three months later, her ITP remains poorly controlled despite adequate first-line therapy. What is the most appropriate next step?

Reveal Answer

Correct answer: B

For recurrent or unresponsive ITP after first-line steroids/IVIG, the next step is thrombopoietin receptor agonists or immunomodulators (e.g., rituximab). Splenectomy is reserved for cases where ITP persists more than 1 year with no improvement on other medications — she is only 3 months in, so it's not yet the appropriate step.

Why the others are wrong A — splenectomy is specifically reserved for persistence beyond 1 year despite other treatments, not an immediate step at 3 months. C — simply repeating first-line therapy without escalation isn't appropriate once it has proven inadequate. D — discharging without further treatment abandons a patient with severe, unresponsive thrombocytopenia (platelet count 9, meeting hospitalization/transfusion-level severity) who needs continued active management. E — heparin is not a treatment for ITP and would be inappropriate; if anything, heparin exposure is relevant to a different diagnosis (HIT).
Exam Pearl ITP treatment ladder: steroids/IVIG (first-line) → thrombopoietin receptor agonists or immunomodulators like rituximab (recurrent/unresponsive) → splenectomy (persistence >1 year despite other treatment). Know the exact 1-year threshold for splenectomy consideration.
Q9HIT Management●●●●● Extreme

A 58-year-old man on heparin for postoperative DVT prophylaxis develops a platelet count drop from 220 to 85 × 10³/µL over 6 days, along with new right leg swelling and pain. Heparin-induced thrombocytopenia (HIT) is suspected. What is the most appropriate immediate management?

Reveal Answer

Correct answer: B

Suspected HIT requires immediate discontinuation of heparin combined with immediate anticoagulation using a non-heparin anticoagulant — this patient's new leg swelling/pain (suggesting an evolving thrombotic event) underscores the prothrombotic danger of HIT, which must be actively treated with anticoagulation, not just heparin cessation.

Why the others are wrong A — continuing heparin, even at a reduced dose, in suspected HIT is dangerous and directly contraindicated. C — stopping heparin alone without starting an alternative anticoagulant leaves the patient at ongoing risk for thromboembolic complications, since HIT is prothrombotic despite the low platelet count. D — platelet transfusion is not the primary intervention for HIT and can potentially worsen thrombotic risk; the priority is stopping heparin and anticoagulating with a non-heparin agent. E — low-molecular-weight heparin is still a heparin product and cross-reacts in HIT; it should be avoided, not substituted in.
Exam Pearl HIT management = stop all heparin (including LMWH) + start a non-heparin anticoagulant immediately. HIT is a paradoxically prothrombotic condition despite low platelets — treat the thrombosis risk, don't just watch the platelet count.
Q10Procedure Thresholds●●●●● Extreme

A 45-year-old woman with a platelet count of 35 × 10³/µL requires a lumbar puncture for suspected meningitis, and separately, her care team is also considering elective cataract surgery in the future. What are the respective platelet thresholds for these two procedures?

Reveal Answer

Correct answer: B

Lumbar puncture falls into the category requiring ≥20 × 10³/µL (along with central venous catheter placement, bone marrow aspiration, and bronchoscopy) — her count of 35 meets this threshold. Ophthalmologic procedures require the highest threshold, ≥100 × 10³/µL (grouped with neurosurgical procedures) — her count of 35 does not meet this higher bar, and platelet correction would be needed before elective cataract surgery.

Why the others are wrong A — the two procedure categories have different thresholds (20 vs. 100), not a shared 50 threshold. C — this reverses the correct thresholds; LP requires the lower 20 threshold, while ophthalmologic procedures require the higher 100 threshold. D — specific thresholds are defined for procedure categories in this framework. E — a platelet count above 10 alone doesn't satisfy the specific procedure-based thresholds; each procedure category has its own higher minimum requirement.
Exam Pearl Three-tier platelet threshold system: ≥20 for LP/central line/bone marrow aspiration/bronchoscopy; ≥50 for most major invasive procedures/surgery; ≥100 for neurosurgical and ophthalmologic procedures. Higher-consequence bleeding sites require higher platelet counts.
Q11Platelet Transfusion Math●●●●● Extreme

A 50-year-old man with a platelet count of 8 × 10³/µL requires transfusion prior to an urgent procedure requiring a threshold of ≥50 × 10³/µL. Approximately how many platelet units should be anticipated to reach this goal, assuming an average per-unit increase?

Reveal Answer

Correct answer: B

He needs to rise from 8 to at least 50 × 10³/µL — an increase of roughly 42 points. Since 1 platelet unit increases the count by approximately 30–40 × 10³/µL, 2 units would be expected to raise his count by roughly 60–80 points, comfortably reaching (and likely exceeding) the goal of 50.

Why the others are wrong A — a single unit (30–40 point rise) would bring him to roughly 38–48, likely still short of the ≥50 threshold. C — 5–6 units would be a substantial overshoot beyond what's needed to reach 50 from a baseline of 8. D — 15 units is a dramatic overestimate and clinically excessive for this goal. E — platelet transfusion is an effective and standard intervention to raise counts pre-procedure; this statement is incorrect.
Exam Pearl 1 platelet unit ≈ 30–40 × 10³/µL rise. Practice this arithmetic — boards can present it as a direct calculation exercise combined with procedure-specific thresholds.
Q12Activity Participation●●●○ Hard

A 16-year-old competitive swimmer with chronic ITP has a stable platelet count of 45 × 10³/µL. She asks what type of physical activity is appropriate for her at this level. What is the most appropriate guidance?

Reveal Answer

Correct answer: B

At a platelet count of 20–50 × 10³/µL, activity should be limited to lower-impact options: resistance training with elastic bands, stationary cycling, range-of-motion exercises, and walking. Vigorous exercise (which would include competitive swimming/contact-risk activities) is reserved for platelet counts ≥50 × 10³/µL.

Why the others are wrong A — complete avoidance is overly restrictive; a defined set of lower-impact activities is specifically recommended at this level, not total inactivity. C — vigorous exercise is reserved for platelet counts ≥50; her count of 45 falls just below this cutoff, so unrestricted vigorous activity isn't yet appropriate. D — this describes the more restrictive 10–20 range guidance, not the 20–50 range she falls into, which does allow some cardiovascular activity (stationary cycling, walking). E — specific, graded guidance does exist for this platelet range.
Exam Pearl Activity tiers: 10–20 → strength training without weights + cardio without strain; 20–50 → resistance bands, stationary cycling, ROM exercises, walking; ≥50 → vigorous exercise permitted. A count of 45 sits just under the vigorous-exercise cutoff.
Q13Hospitalization Indications●●●● Very Hard

A 29-year-old woman with newly discovered thrombocytopenia (platelet count 42 × 10³/µL) has no bleeding, normal hemoglobin and WBC, and no other symptoms. She is otherwise healthy. What is the most appropriate disposition?

Reveal Answer

Correct answer: B

She does not meet any of the specific hospitalization criteria: platelet count is not <10, there's no evidence of hemolysis, no new neurologic/renal dysfunction, no life-threatening hemorrhage, no associated anemia/leukopenia/leukocytosis, and no severe illness like sepsis. Outpatient workup and management is therefore reasonable.

Why the others are wrong A/E — thrombocytopenia alone, without meeting specific severity/complication criteria, does not mandate hospitalization; a platelet count below 100 alone is not, by itself, one of the listed hospitalization triggers. C — splenectomy is a late-stage treatment for confirmed, refractory ITP (persistence >1 year), entirely inappropriate for a new, asymptomatic finding. D — platelet transfusion is indicated for counts <10, active hemorrhage, or pre-procedure — none apply here.
Exam Pearl Hospitalization triggers are specific, not simply "any thrombocytopenia": platelet <10, hemolysis, new neuro/renal dysfunction, heparin exposure with coagulation abnormality or vascular findings, life-threatening hemorrhage, anemia, leukopenia, leukocytosis, or severe illness (e.g., sepsis). Absent these, outpatient evaluation is appropriate.
Q14Integrative — Differential Diagnosis●●●●● Extreme

A 63-year-old man on unfractionated heparin for atrial fibrillation develops a platelet count drop from 210 to 60 × 10³/µL over 7 days, along with new painful, discolored toes bilaterally. He has no fever, no schistocytes on smear, and normal hemoglobin. Which diagnosis is most likely, and what distinguishes it from the other thrombocytopenia etiologies being considered?

Reveal Answer

Correct answer: B

This is the classic presentation of HIT: thrombocytopenia developing in the setting of heparin exposure, with new vascular findings (painful, discolored toes suggesting thrombosis/ischemia) — heparin exposure with associated vascular findings is a specifically listed hospitalization/high-concern indicator. The absence of schistocytes and hemolysis helps distinguish this from TTP/HUS.

Why the others are wrong A — TTP classically shows schistocytes and evidence of hemolysis, both absent here, making HIT the better fit given his heparin exposure and thrombotic toe findings. C — ITP is a diagnosis of exclusion for isolated thrombocytopenia without another identifiable cause; his clear heparin exposure with temporally-linked count drop and vascular findings points specifically to HIT rather than ITP. D — his presentation is specifically and classically tied to heparin (the temporal relationship and vascular complications are hallmark HIT features), not an unrelated drug. E — his findings (real thrombotic vascular complications) indicate a true, clinically significant process, not a laboratory artifact.
Exam Pearl HIT recognition triad: heparin exposure + falling platelet count (usually 5–10 days after exposure) + new thrombotic/vascular findings (arterial or venous) — schistocytes and hemolysis argue against it in favor of TTP/HUS instead.
Q15Integrative — Comprehensive Case●●●●● Extreme

A 68-year-old woman presents with fatigue and easy bruising. CBC shows platelet count 38 × 10³/µL, with normal hemoglobin and WBC. Repeat count in a citrate tube confirms true thrombocytopenia. Peripheral smear shows no schistocytes. She takes no new medications and has no heparin exposure. Given her age and isolated finding, what is the most appropriate comprehensive next step?

Reveal Answer

Correct answer: B

While her presentation (isolated thrombocytopenia, no schistocytes, confirmed on repeat testing) is broadly consistent with a picture where ITP could be considered, her age >60 specifically mandates evaluation for myelodysplastic syndrome and lymphoproliferative disorders before settling on ITP as a diagnosis of exclusion. Standard additional workup (as clinically indicated) should also be pursued.

Why the others are wrong A — ITP being a diagnosis of exclusion means other causes—especially the age-specific MDS/lymphoproliferative workup—must be considered first, not skipped. C — excluding pseudo-thrombocytopenia is only the first step; her age-specific and general thrombocytopenia workup still needs to be completed. D — splenectomy is a late-line ITP treatment for confirmed, refractory disease persisting beyond a year, not an immediate step in a new diagnostic workup. E — empirical treatment without adequate diagnostic evaluation, especially in an older patient with a broader differential to exclude, is inappropriate.
Exam Pearl Age >60 with isolated thrombocytopenia adds a mandatory extra branch to the workup (MDS/lymphoproliferative evaluation) on top of the standard thrombocytopenia workup (smear, targeted labs, exclusion of pseudo-thrombocytopenia) — don't let a "clean-looking" isolated thrombocytopenia case skip this age-based step.
Thrombocytopenia Board Review · Case-Based MCQ Set · 15/15 Questions